Perspective Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Perspective Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • Perspective Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 7, 2024 was 67.6M shares, a 75.9% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 67.6M -213M -75.9% Nov 7, 2024 10-Q 2024-11-12
Q2 2024 67.4M -213M -76% Aug 7, 2024 10-Q 2024-08-13
Q1 2024 587M +307M +110% Mar 22, 2024 10-K 2024-03-28
Q3 2023 281M +138M +97.4% Nov 10, 2023 10-Q 2023-11-14
Q2 2023 281M Aug 9, 2023 10-Q 2023-08-11
Q1 2023 280M +138M +97.1% Apr 27, 2023 10-KT 2023-05-01
Q3 2022 142M +198K +0.14% Sep 23, 2022 10-K 2022-09-28
Q1 2022 142M +575K +0.41% May 9, 2022 10-Q 2022-05-13
Q4 2021 142M +840K +0.6% Feb 7, 2022 10-Q 2022-02-09
Q3 2021 142M +73M +106% Sep 23, 2021 10-K 2021-09-27
Q1 2021 141M +73.8M +109% May 12, 2021 10-Q 2021-05-14
Q4 2020 141M +73.5M +109% Feb 8, 2021 10-Q 2021-02-09
Q3 2020 68.9M +1.51M +2.24% Sep 21, 2020 10-K 2020-09-25
Q1 2020 67.7M +313K +0.46% May 11, 2020 10-Q 2020-05-13
Q4 2019 67.7M +319K +0.47% Feb 11, 2020 10-Q 2020-02-12
Q3 2019 67.4M +56.9K +0.09% Sep 24, 2019 10-K 2019-09-27
Q1 2019 67.3M +12.2M +22.2% May 8, 2019 10-Q 2019-05-10
Q4 2018 67.3M +12.2M +22.2% Feb 11, 2019 10-Q 2019-02-13
Q3 2018 67.3M +12.3M +22.4% Sep 24, 2018 10-K 2018-09-26
Q1 2018 55.1M +82.8K +0.15% May 2, 2018 10-Q 2018-05-04
Q4 2017 55.1M +82.8K +0.15% Feb 7, 2018 10-Q 2018-02-09
Q3 2017 55M +6.8K +0.01% Sep 25, 2017 10-K 2017-09-28
Q1 2017 55M +6.8K +0.01% May 10, 2017 10-Q 2017-05-10
Q4 2016 55M +3.87K +0.01% Feb 7, 2017 10-Q 2017-02-09
Q3 2016 55M -2.93K -0.01% Sep 1, 2016 10-K 2016-09-09
Q1 2016 55M +103K +0.19% May 6, 2016 10-Q 2016-05-10
Q4 2015 55M +130K +0.24% Feb 8, 2016 10-Q 2016-02-09
Q3 2015 55M +130K +0.24% Oct 19, 2015 10-Q 2015-11-09
Q1 2015 54.9M +514K +0.95% May 8, 2015 10-Q 2015-05-15
Q4 2014 54.9M +13.3M +32.1% Feb 11, 2015 10-Q 2015-02-17
Q3 2014 54.9M +16.5M +42.9% Sep 26, 2014 10-K 2014-09-29
Q1 2014 54.4M +19.8M +57.2% May 7, 2014 10-Q 2014-05-15
Q4 2013 41.5M +6.93M +20% Feb 6, 2014 10-Q 2014-02-14
Q3 2013 38.4M +3.83M +11.1% Sep 27, 2013 10-K 2013-09-30
Q1 2013 34.6M +5.3M +18.1% May 1, 2013 10-Q 2013-05-15
Q4 2012 34.6M +5.3M +18.1% Feb 6, 2013 10-Q 2013-02-14
Q3 2012 34.6M +5.6M +19.3% Sep 25, 2012 10-K/A 2012-10-26
Q1 2012 29.3M May 4, 2012 10-Q 2012-05-15
Q4 2011 29.3M Feb 3, 2012 10-Q 2012-02-14
Q3 2011 29M Nov 7, 2011 10-Q/A 2011-12-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.